Irhythm Technologies Inc (NASDAQ:IRTC) insider Kevin M. King sold 60,000 shares of the business’s stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $88.76, for a total value of $5,325,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
Shares of IRTC traded up $2.75 on Tuesday, reaching $94.01. 435,996 shares of the stock traded hands, compared to its average volume of 397,770. Irhythm Technologies Inc has a 12 month low of $55.18 and a 12 month high of $98.37. The stock has a market cap of $2.23 billion, a PE ratio of -49.74 and a beta of 1.79. The company has a current ratio of 3.52, a quick ratio of 3.45 and a debt-to-equity ratio of 0.64.
Irhythm Technologies (NASDAQ:IRTC) last announced its quarterly earnings results on Tuesday, February 12th. The company reported ($0.48) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.45) by ($0.03). Irhythm Technologies had a negative net margin of 32.78% and a negative return on equity of 69.79%. The company had revenue of $43.16 million during the quarter, compared to the consensus estimate of $40.21 million. During the same quarter last year, the company earned ($0.48) earnings per share. The business’s revenue was up 53.2% on a year-over-year basis. Equities analysts forecast that Irhythm Technologies Inc will post -1.65 earnings per share for the current fiscal year.
Large investors have recently made changes to their positions in the business. BlackRock Inc. grew its holdings in shares of Irhythm Technologies by 5.0% during the third quarter. BlackRock Inc. now owns 2,216,983 shares of the company’s stock worth $209,858,000 after purchasing an additional 105,780 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Irhythm Technologies by 54.0% during the third quarter. Vanguard Group Inc. now owns 1,350,269 shares of the company’s stock worth $127,816,000 after purchasing an additional 473,235 shares during the last quarter. Vanguard Group Inc grew its holdings in shares of Irhythm Technologies by 54.0% during the third quarter. Vanguard Group Inc now owns 1,350,269 shares of the company’s stock worth $127,816,000 after purchasing an additional 473,235 shares during the last quarter. Millennium Management LLC grew its holdings in shares of Irhythm Technologies by 30.6% during the fourth quarter. Millennium Management LLC now owns 977,269 shares of the company’s stock worth $67,901,000 after purchasing an additional 229,090 shares during the last quarter. Finally, Lord Abbett & CO. LLC grew its holdings in shares of Irhythm Technologies by 2.6% during the fourth quarter. Lord Abbett & CO. LLC now owns 738,676 shares of the company’s stock worth $51,323,000 after purchasing an additional 18,488 shares during the last quarter.
ILLEGAL ACTIVITY WARNING: “Irhythm Technologies Inc (IRTC) Insider Kevin M. King Sells 60,000 Shares” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/4233620/irhythm-technologies-inc-irtc-insider-kevin-m-king-sells-60000-shares.html.
Irhythm Technologies Company Profile
iRhythm Technologies, Inc, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias.
Featured Article: The Structure of a Futures Contract
Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.